Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?

Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review

(2020) Benedikt Pleuhs et al.   AIDS PATIENT CARE AND STDS

Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value?

(2020) Douglas S. Krakower et al.   ANNALS OF INTERNAL MEDICINE

Comparative Pricing of Branded Tenofovir Alafenamide–Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate–Emtricitabine for HIV Preexposure Prophylaxis

(2020) Rochelle P. Walensky et al.   ANNALS OF INTERNAL MEDICINE

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

(2020) Kenneth H Mayer et al.   LANCET

Product Hopping—An Expensive and Wasteful Practice

(2020) Jennifer D. Claytor et al.   JAMA Internal Medicine

Recruiting vulnerable populations to participate in HIV prevention research: Findings from the Together 5,000 cohort study

(2019) Christian Grov et al.   ANNALS OF EPIDEMIOLOGY

Changing prescribing behaviours with educational outreach: an overview of evidence and practice

(2019) Breanne E. Kunstler et al.   BMC Medical Education

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

(2019) Kai Juhani Kauppinen et al.   AIDS PATIENT CARE AND STDS

Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data

(2018) Manvi Sharma et al.   BMC HEALTH SERVICES RESEARCH

Academic Detailing

(2017) Jerry Avorn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States

(2017) Marissa King et al.   SOCIAL SCIENCE & MEDICINE

Two years of sunshine: has openness about payments reduced industry influence in healthcare?

(2016) Jeanne Lenzer   BMJ-British Medical Journal

Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study

(2016) William Fleischman et al.   BMJ-British Medical Journal

Two years of sunshine: has openness about payments reduced industry influence in healthcare?

(2016) Jeanne Lenzer   BMJ-British Medical Journal

Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study

(2016) William Fleischman et al.   BMJ-British Medical Journal

Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries

(2016) Colette DeJong et al.   JAMA Internal Medicine

Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry

(2016) Chie Hoon Song et al.   SpringerPlus

Effectiveness of Academic Detailing to Optimize Medication Prescribing Behaviour of Family Physicians

(2016) Harpreet K Chhina et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?

(2016) Reed F. Beall et al.   PLoS One

Effect of Physician Payment Disclosure Laws on Prescribing

(2012) Genevieve Pham-Kanter et al.   ARCHIVES OF INTERNAL MEDICINE

FDA paves the way for pre-exposure HIV prophylaxis

(2012) David Holmes   LANCET

All Gifts Large and Small: Toward an Understanding of the Ethics of Pharmaceutical Industry Gift-Giving

(2010) Dana Katz et al.   AMERICAN JOURNAL OF BIOETHICS